New combo therapy for relapsed myeloma shows promise but study halted early
NCT ID NCT01794572
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This study tested a powerful combination of total bone marrow irradiation and high-dose chemotherapy (melphalan) followed by a stem cell transplant in 13 people whose multiple myeloma had returned after initial treatment. The goal was to find the safest highest radiation dose and see how well it controlled the cancer. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA IN RELAPSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Claude Huriez, service d'hématologie
Lille, 59037, France
-
CHU Haut-Leveque, service d'Hématologie
Bordeaux, 33604, France
-
CHU Hautepierre, service d'hématologie
Strasbourg, 67098, France
-
CHU Hotel-Dieu, service d'hématologie
Nantes, 44093, France
-
CLCC Bergonie, service de radiotherapie
Bordeaux, 33076, France
-
CLCC ICO, service de radiothérapie
Saint-Herblain, 44805, France
-
CLCC Oscar Lambret, service de radiothérapie
Lille, 59020, France
-
CLCC Paul Strauss, service de radiothérapie
Strasbourg, 67091, France
Conditions
Explore the condition pages connected to this study.